Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ANI Pharmaceuticals Inc (NASDAQ:ANIP)

66.46
BATS BZX Real-Time Price
As of 10:29am ET
 +0.28 / +0.42%
Today’s Change
26.80
Today|||52-Week Range
70.92
+47.28%
Year-to-Date
Pain Therapeutics (PTIE) Down on CRL for Chronic Pain Drug
Sep 28 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Files sNDA for Blood Cancer Drug Imbruvica
Sep 27 / Zacks.com - Paid Partner Content
Jazz Pharma Closes Enrollment in OSA Drug Phase III Trial
Sep 28 / Zacks.com - Paid Partner Content
Amarin Corporation (AMRN) Looks Good: Stock Adds 6.1% in Session
Sep 27 / Zacks.com - Paid Partner Content
AcelRx (ACRX) Initiates Phase III IAP312 Study on Zalviso
Sep 28 / Zacks.com - Paid Partner Content
Achillion, J&J HCV Triple Combination Drug Data Presented
Sep 26 / Zacks.com - Paid Partner Content
Juno Therapeutics (JUNO) Catches Eye: Stock Jumps 13%
Sep 28 / Zacks.com - Paid Partner Content
AbbVie (ABBV) HCV Combination Drug Positive in Phase IIIb
Sep 26 / Zacks.com - Paid Partner Content
Amgen's Multiple Myeloma Drug Kyprolis Fails in Phase III
Sep 28 / Zacks.com - Paid Partner Content
Strength Seen in NewLink Genetics (NLNK): Stock Jumps 5%
Sep 26 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close66.18
Today’s open66.21
Day’s range66.18 - 66.51
Volume301
Average volume (3 months)228,178
Market cap$762.0M
Dividend yield--
Data as of 10:29am ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-49.03%
Earnings growth (this year)+51.29%
Earnings growth (next 5 years)+15.40%
Revenue growth (last year)+36.36%
P/E ratio78.0
Price/Sales6.83
Price/Book4.76

Competitors

 Today’s
change
Today’s
% change
BPMCBlueprint Medicines ...+0.61+2.17%
RTRXRetrophin Inc+0.06+0.27%
MNTAMomenta Pharmaceutic...+0.07+0.61%
AMAGAMAG Pharmaceuticals...0.000.00%
Data as of 10:32am ET, 09/30/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)$1.09
Annual revenue (last year)$76.3M
Annual profit (last year)$15.3M
Net profit margin20.03%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur S. Przybyl
Vice President-
Operations
James G. Marken
Corporate headquarters
Baudette, Minnesota

Forecasts

Search for Jobs